BCI Marketplace
Epilepsy Neurotechnology trials

Sleep-Sensitive Seizure Risk Assessment With Wearable EEGs

RecruitingNCT06545643Phase: NAStarted 2025-05-01

Summary

Epilepsy, a prevalent neurological disorder, affects 40% of patients with uncontrolled seizures despite medications. Sleep disturbance exacerbates epilepsy, and vice versa, but existing literature suffers from limitations. Studies conducted in hospital settings provide only brief observation periods and fail to capture the natural sleep environment. Wearable technology offers a promising solution, providing a nuanced understanding of the relationship between seizures and sleep. The Dreem headban

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
None

Inclusion Criteria: * Age \> 18 years * At least 2 seizures per week based on clinical notes * Patients where medications will stay stable over the study period * 40% of both spikes and spindles are identifiable on the dreem headband based on the screening night Exclusion Criteria: * Cognitive im

Locations

Duke University Health System
Durham, North Carolina, United States

Interested in participating? View the full study details on ClinicalTrials.gov:

View on ClinicalTrials.gov →